Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 402 followers
Latest posts
Last updated about 5 hours ago
FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype
about 5 hours ago
The early FDA approval doesn't change Pfizer and Arvinas' plan to leave...
Look out Rexulti, Axsome's Auvelity has its nod for Alzheimer's agitation
about 9 hours ago
Four years after gaining FDA approval for Auvelity to treat major depressive...
Cardio drug developer Esperion to go private in potential $1.1B buyout by ArchiMed
about 9 hours ago
Shortly after laying out $75 million upfront for Corstasis Therapeutics and its...
Union workers at Korean CDMO Samsung Biologics kick off strike
about 9 hours ago
The company looks to achieve an "amicable resolution as soon as possible"...
Summit's PD-1xVEGF interim trial miss surprises analysts, shares tumble
about 9 hours ago
A surprise interim trial miss in ivonescimab’s closely watched Harmoni-3 trial has...
FDA expectations create potential friction in new Form 483 response guidance
about 10 hours ago
Looking to clarify its expectations on manufacturer responses following inspections, the FDA...
A pivotal time for an RNA pioneer
about 12 hours ago
Fierce's Angus Liu speaks with Ionis CEO Brett Monia about the science...
Fierce Pharma Asia—Sun’s $11.75B Organon buy; Astellas’ Xtandi peak; BeOne’s PD-1xVEGF bet
about 12 hours ago
Sun Pharma will acquire Organon for $11.75 billion. Astellas projects Xtandi sales...
Repatha sales help Amgen overcome Prolia biosimilar hits in 1st quarter
about 12 hours ago
Amgen will rely on the emergence of its newer products in 2026...
Novo Nordisk’s Rybelsus officially retired in US as ‘Ozempic pill’ takes branding center stage
about 12 hours ago
The semaglutide franchise is changing up its branding as Novo Nordisk, seeing...
Verastem launches ‘Reimagine’ campaign to move ovarian cancer drugs into earlier lines
about 15 hours ago
Verastem Oncology has launched a marketing campaign for its co-packaged cancer drugs...
BMS 'well prepared' for Camzyos competition as revenue from new products overtakes legacy portfolio
1 day ago
Bristol Myers Squibb’s growth portfolio is offsetting declines in older products as...